NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS

Fuente: WIPO "tomato"
The present disclosure provides bispecific antibodies or antigen-binding fragments capable of binding to LILRB4 and CD3, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.